PTC (NASDAQ: PTC) Q4 2024 Earnings Call Nov 06, 2024, 5:00 p.m. ET ...

and the factors discussed in the "Risk Factors" section of PTC's most recent Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time in PTC's other filings ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over to ...

The United States Department of Transportation’s Federal Railroad Administration (FRA) said yesterday it has published a notice of proposed rulemaking (NPRM) focused on regulations related to Positive ...

Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ETCompany ParticipantsEric Micek - VP, IRJim Burke - President ...

On November 6, 2024, the Company's Board of Directors declared, approved, and authorized payment of a quarterly dividend of $0.12 per share pursuant to the Company's dividend policy. The dividend will ...

BigTime Software has announced the acquisition of WorkRails to extend the capabilities of its PSA solutions with CPQ, SoW, and workflow capabilities.

Alhemo, for its part, works by allowing blood clots to form ... up at PTC Therapeutics’ Translarna, the latest in a series of European setbacks for the drug. CHMP first rejected a full approval ...

A recent article published in Scientific Reports has explored the potential of a hybrid solar power plant capable of ...

Correspondence to: Dr J R de Kruijk, Department of Neurology, University Hospital Maastricht, P Debeylaan 25, NL 6229 HX Maastricht, The Netherlands; jdk{at}sneu.azm.nl Background: Outcome after mild ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy that ...